Recommended Topic Related To:

Rhophylac

"The U.S. Food and Drug Administration yesterday approved Rixubis [Coagulation Factor IX (Recombinant)] for use in people with hemophilia B who are 16 years of age and older. Rixubis is indicated for the control and prevention of bleeding episodes"...

Rhophylac




Overdosage
Contraindications

OVERDOSE

There are no reports of known overdoses in patients being treated for suppression of Rh isoimmunization or ITP. Patients with incompatible transfusion or ITP who receive an overdose of Rh0(D) immune globulin should be monitored because of the risk of hemolysis.

CONTRAINDICATIONS

Individuals known to have had an anaphylactic or severe systemic reaction to the administration of human immune globulin products should not receive Rh0(D) immune globulin.

Last reviewed on RxList: 5/18/2007
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.